CELG
Celgene Corporation
Biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases
CUSIP: 151020104HealthcareUS5 holders
Total Value
$1.22B
Total Shares
12.94M
Net Share Change
+12.10M
Activity
4 buying1 selling
Investor
Value
Shares
Weight
Change
Abrams Capital Management
$637.07M6.75M sharesNEW
